Chugai Pharma USA, Inc.
United States of America (USA)
1 August 2018 - 31 July 2019
Principal institution: Chugai Pharmaceutical Co., Ltd.
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Chugai Pharma USA, Inc. published between 1 August 2018 - 31 July 2019 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
| AC | FC |
|---|---|
| 1 | 0.33 |
Outputs by subject (FC)
| Subject | AC | FC | |
|---|---|---|---|
| Life Sciences | 1 | 0.33 | |
| Chemistry | 1 | 0.33 | |
Top articles by Altmetric score in current window
ZFAND5/ZNF216 is an activator of the 26S proteasome that stimulates overall protein degradation.
Proceedings of the National Academy of Sciences of the United States of America
2018-09-25
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
